|Articles|March 18, 2020

Contagion Live News Network: Coronavirus Updates for March 18, 2020

Stay on top of coronavirus developments from March 18, 2020.

There are now more than 210,000 cases of COVID-19 across the globe. Worldwide, more than 83,000 individuals have recovered from the novel coronavirus, and 8000 have died from the disease.

The highest number of cases remains in China with over 81,000 confirmed cases of the virus. Italy has seen the second highest surge of the virus with more than 35,000 cases. Over the span of 24 hours cases have increased by 4207, marking the largest jump in a single day.

In the United States cases have surpassed 7300. New York remains the hotspot of the US outbreak with a reported 2480 cases of COVID-19 with 16 linked deaths. Across the country in Washington State, there have been more than 1000 confirmed cases, with 55 associated deaths reported.

Let’s take a look at the latest developments in the COVID-19 pandemic from March 18th:

The US senate passed a coronavirus relief legislation this afternoon. This measure will now go to President Trump for approval. The legislation will "include provisions" for free COVID-19 testing along with paid emergency leave.

In a press briefing in Geneva, Tedros Adhanom Ghebreyesus, PhD, director-general of the World Health Organization, announced the organization of an international study to evaluate treatments for COVID-19.

“The SOLIDARITY trial provides simplified procedures to enable even hospitals that have been overloaded to participate,” Tedros said. “Many countries have already confirmed that they will join the SOLIDARITY trial - Argentina, Bahrain, Canada, France, Iran, Norway, South Africa, Spain, Switzerland and Thailand - and I trust many more will join.”

The WHO also announced that ibuprofen is not recommended for managing symptoms of coronavirus.

Canadian Prime Minister Justin Trudeau announced that Canada and the United States have mutually decided to temporarily halt all non-essential travel across the border. This was announced a day after the European Union decided to close borders for 30 days.

Be sure to check out new articles on Contagion® including a summary of US Food and Drug Administration guidance on conducting clinical trials during this pandemic. Another article details the steps that Italy took to mitigate the coronavirus crisis in their country.

A new episode of the Contagion® Connect podcast features an interview with Seth Bourg, an American citizen who is employed as a teacher in China. Bourg shares his experiences on being quarantined in his apartment near the hot zone of the COVID-19 pandemic.

Contagion® News Network videos will return tomorrow, March 19th.

On March 25, 2020, at 6PM ET, Contagion® is hosting a live CME webinar on what clinicians need to know amid the COVID-19 pandemic. Register here.


Related to this article

Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.